Top 50 thought-leaders in orphan drugs & rare disease

In Advocacy, Clinical Development, Regulation & Government, Reports by Caroline HornbyLeave a Comment

top 50 orphan drug thought-leaders

This report recognizes the top 50 thought-leaders in orphan drugs and rare disease.

Download a copy of the report here.

The thought-leaders include representatives from industry, patient advocacy groups, research institutions, government and media from around the world.

They were  selected based on the following criteria:

  • Research & methodology
  • Leadership
  • Awards & recognition
  • Community engagement & impact

Download a copy of the report today to find out who is pioneering orphan drug research, awareness and legislation.

You may also be interested in participating at World Orphan Drug Congress USA on April 23-25, 2014. World Orphan Drug Congress USA is the largest international, commercially-focused event for the advancement of rare disease research and orphan drug development. Download the prospectus here for more information.

Leave a Comment

Current ye@r *